Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue BMJ Open Année : 2022

Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol

Caroline Caramella
  • Fonction : Auteur
  • PersonId : 1091231
Marc Zins
Elie Fadel
  • Fonction : Auteur
  • PersonId : 852957
Olaf Mercier

Résumé

Eligibility criteria definition for a lung cancer screening (LCS) is an unmet need. We hypothesised that patients with a history of atheromatous cardiovascular disease (ACVD) associated with tobacco consumption are at risk of lung cancer (LC). The main objective is to assess LC prevalence among patients with ACVD and history of tobacco consumption by using low-dose chest CT scan. Secondary objectives include the evaluation LCS in this population and the constitution of a biological biobank to stratify risk of LC.
Fichier principal
Vignette du fichier
e067191.full.pdf (261.18 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03926501 , version 1 (16-11-2023)

Identifiants

Citer

David Boulate, Marine Fidelle, Caroline Caramella, Justin Issard, Olivier Planche, et al.. Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol. BMJ Open, 2022, 12 (12), ⟨10.1136/bmjopen-2022-067191⟩. ⟨hal-03926501⟩
80 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More